Christopher Ayscue-Tse

Senior Manager, Regulatory Affairs at Akero Therapeutics - South San Francisco, CA, US

Christopher Ayscue-Tse's Colleagues at Akero Therapeutics
Kitty Yale

EVP and Chief Development Officer

Contact Kitty Yale

John CEP

Vice President Finance and Controller

Contact John CEP

William White

CFO and Head of Corporate Development

Contact William White

Brittany De Temple

director of clinical operations and program management

Contact Brittany De Temple

Yuan Xu

Independent Board Director

Contact Yuan Xu

View All Christopher Ayscue-Tse's Colleagues
Christopher Ayscue-Tse's Contact Details
HQ
650-487-6488
Location
San Francisco,California,United States
Company
Akero Therapeutics
Christopher Ayscue-Tse's Company Details
Akero Therapeutics logo, Akero Therapeutics contact details

Akero Therapeutics

South San Francisco, CA, US • 20 - 49 Employees
BioTech/Drugs

Akero Therapeutics is a clinical-stage cardio-metabolic company developing transformational treatments for non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. Akero's lead product candidate, efruxifermin (EFX), an engineered Fc-FGF21 fusion protein, is currently being evaluated in a Phase 2b clinical trial as a potential treatment for NASH. Akero is headquartered in South San Francisco.

N/A
Details about Akero Therapeutics
Frequently Asked Questions about Christopher Ayscue-Tse
Christopher Ayscue-Tse currently works for Akero Therapeutics.
Christopher Ayscue-Tse's role at Akero Therapeutics is Senior Manager, Regulatory Affairs.
Christopher Ayscue-Tse's email address is ***@akerotx.com. To view Christopher Ayscue-Tse's full email address, please signup to ConnectPlex.
Christopher Ayscue-Tse works in the Research industry.
Christopher Ayscue-Tse's colleagues at Akero Therapeutics are Kitty Yale, Yasmine CPA, John CEP, William White, Whitney Withington, Brittany De Temple, Yuan Xu and others.
Christopher Ayscue-Tse's phone number is 650-487-6488
See more information about Christopher Ayscue-Tse